SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-23-084840
Filing Date
2023-07-27
Accepted
2023-07-27 17:15:14
Documents
7
Group Members
JEREMY C. GREEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm2322134d1_sc13d.htm SC 13D 75910
2 EXHIBIT 99.1 tm2322134d1_ex99-1.htm EX-99.1 5216
3 EXHIBIT 99.2 tm2322134d1_ex99-2.htm EX-99.2 70882
4 EXHIBIT 99.3 tm2322134d1_ex99-3.htm EX-99.3 62261
5 EXHIBIT 99.4 tm2322134d1_ex99-4.htm EX-99.4 61364
6 EXHIBIT 99.5 tm2322134d1_ex99-5.htm EX-99.5 36710
7 EXHIBIT 99.6 tm2322134d1_ex99-6.htm EX-99.6 36791
  Complete submission text file 0001104659-23-084840.txt   350916
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88050 | Film No.: 231119421
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D